Peginterferon-α-2b
Transcript of Peginterferon-α-2b
Reactions 1306 - 19 Jun 2010
SPeginterferon-α-2b
Sensorineural hearing loss: case reportA 60-year-old man, who had previously received
interferon-α and ribavirin for 12 months, started receivingSC peginterferon-α-2b [Pegintron] 100 µg/week withribavirin for chronic hepatitis C virus infection. Hepresented 42 weeks later with sudden right-sided tinnitusand deafness. Right ear hearing loss was noted at 0-90dBduring audiometry, and sensorineural hearing loss wasdiagnosed. Peginterferon-α-2b was withdrawn, and a10-day course of prednisolone was started. After thiscourse, his hearing had almost normalised. Full recoverywas observed 6 months later.
Author comment: It is thought that treatment withpeginterferon-α-2b requires careful observation of thehearing.Shin MK, et al. [A case of sudden-onset hearing loss in a patient treated withpeginterferon alpha-2b and ribavirin for chronic hepatitis C]. Korean Journal ofHepatology 15: 370-4, No. 3, Sep 2009 [Korean; summarised from a translation] -South Korea 803020204
1
Reactions 19 Jun 2010 No. 13060114-9954/10/1306-0001/$14.95 © 2010 Adis Data Information BV. All rights reserved